Leukocyte-Mediated Combined Targeted Chemo and Gene Therapy for Esophageal Cancer-Reference-Cited by-同舟云学术

Leukocyte-Mediated Combined Targeted Chemo and Gene Therapy for Esophageal Cancer

Published:2020-09-30 Issue:42 Volume:12 Page:47330-47341
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Jun Yali¹,Tang Zhuang¹,Luo Chao¹,Jiang Baofei²,Li Xiang¹,Tao Mingyue³,Gu Hao¹,Liu Lu⁴,Zhang Zhengwei⁴,Sun Su’An⁴,Han Kairong¹,Yu Xiaojuan³,Song Xudong²,Tao Guoquan²,Chen Xiaofei³,Zhang Li¹,Gao Yong³,Wang Qi-long¹^ORCID

Affiliation:

1. Department of Central Laboratory, The Affiliated Huaian No.1 People’s Hospital, Nanjing Medical University, Huai’an 223300, China

2. Department of Clinical Oncology, The Affiliated Huaian No.1 People’s Hospital, Nanjing Medical University, Huai’an 223300, China

3. Department of General Surgery, The Affiliated Huaian No.1 People’s Hospital, Nanjing Medical University, Huai’an 223300, China

4. Department of Pathology, The Affiliated Huaian No.1 People’s Hospital, Nanjing Medical University, Huai’an 223300, China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Key Laboratory Projects of Huai'an

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.0c15419

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer incidence and mortality in China, 2014

3. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study

4. Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer

5. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2–Positive Esophageal Adenocarcinoma: TRAP Study

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticles Combining Gene Therapy and Chemotherapy as a Treatment for Gastrointestinal Tumors: A Systematic Review;Applied Sciences;2024-09-04

2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

3. Advanced gene therapy system for the treatment of solid tumour: A review;Materials Today Bio;2024-08

4. Advances in Tumor Targeting Biomimetic Drug Delivery Systems: A Promising Approach for Antitumor Therapy;Pharmaceutical Fronts;2024-05-22

5. Development of a Specific Aptamer‐Modified Nano‐System to Treat Esophageal Squamous Cell Carcinoma;Advanced Science;2024-05-05